NDC11 63323034101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63323-0341-01 | 63323-0341 |
| 63323-0341-1 | 63323-0341 |
| 63323-341-01 | 63323-341 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefoxitin | CEFOXITIN SODIUM | Fresenius Kabi USA, LLC | 2a9d1e7b-96ee-4e6c-a1e8-47b76b924422 | 2023-07-10 | Warnings, Adverse reactions | 63323-341 |
| Cefoxitin | CEFOXITIN SODIUM | Fresenius Kabi USA, LLC | d02170ff-65aa-48b8-a922-94271c46ffa7 | 2022-09-23 | Warnings, Adverse reactions | 63323-341-01 63323-341 63323034101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.